nodes	percent_of_prediction	percent_of_DWPC	metapath
Olopatadine—S100A1—connective tissue—Graves' disease	0.0702	0.0724	CbGeAlD
Olopatadine—S100A13—eye—Graves' disease	0.0646	0.0667	CbGeAlD
Olopatadine—S100B—eye—Graves' disease	0.0629	0.0649	CbGeAlD
Olopatadine—S100A13—connective tissue—Graves' disease	0.0623	0.0642	CbGeAlD
Olopatadine—S100A12—connective tissue—Graves' disease	0.0614	0.0634	CbGeAlD
Olopatadine—S100B—connective tissue—Graves' disease	0.0606	0.0625	CbGeAlD
Olopatadine—S100A2—pituitary gland—Graves' disease	0.0587	0.0606	CbGeAlD
Olopatadine—S100A2—adipose tissue—Graves' disease	0.0585	0.0603	CbGeAlD
Olopatadine—S100A1—pituitary gland—Graves' disease	0.0541	0.0558	CbGeAlD
Olopatadine—S100A1—adipose tissue—Graves' disease	0.0538	0.0556	CbGeAlD
Olopatadine—S100A2—thyroid gland—Graves' disease	0.0506	0.0522	CbGeAlD
Olopatadine—S100A13—adipose tissue—Graves' disease	0.0478	0.0493	CbGeAlD
Olopatadine—S100A12—pituitary gland—Graves' disease	0.0473	0.0488	CbGeAlD
Olopatadine—S100A12—adipose tissue—Graves' disease	0.0471	0.0486	CbGeAlD
Olopatadine—S100A1—thyroid gland—Graves' disease	0.0466	0.0481	CbGeAlD
Olopatadine—S100B—adipose tissue—Graves' disease	0.0465	0.048	CbGeAlD
Olopatadine—S100A13—thyroid gland—Graves' disease	0.0414	0.0427	CbGeAlD
Olopatadine—HRH1—eye—Graves' disease	0.0129	0.0133	CbGeAlD
Olopatadine—HRH1—connective tissue—Graves' disease	0.0124	0.0128	CbGeAlD
Olopatadine—HRH1—adipose tissue—Graves' disease	0.00954	0.00984	CbGeAlD
Olopatadine—S100A12—TRAF6 mediated NF-kB activation—IFIH1—Graves' disease	0.00512	0.167	CbGpPWpGaD
Olopatadine—S100B—TRAF6 mediated NF-kB activation—IFIH1—Graves' disease	0.00484	0.158	CbGpPWpGaD
Olopatadine—S100A2—Validated transcriptional targets of TAp63 isoforms—FAS—Graves' disease	0.00399	0.13	CbGpPWpGaD
Olopatadine—S100A2—p73 transcription factor network—FAS—Graves' disease	0.00294	0.0959	CbGpPWpGaD
Olopatadine—S100A12—RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways—IFIH1—Graves' disease	0.00196	0.0637	CbGpPWpGaD
Olopatadine—S100A2—Direct p53 effectors—FAS—Graves' disease	0.00186	0.0607	CbGpPWpGaD
Olopatadine—S100B—RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways—IFIH1—Graves' disease	0.00185	0.0603	CbGpPWpGaD
Olopatadine—HRH1—GPCRs, Class A Rhodopsin-like—GPR174—Graves' disease	0.00101	0.033	CbGpPWpGaD
Olopatadine—S100A12—Innate Immune System—IFIH1—Graves' disease	0.000402	0.0131	CbGpPWpGaD
Olopatadine—S100B—Innate Immune System—IFIH1—Graves' disease	0.000381	0.0124	CbGpPWpGaD
Olopatadine—S100A12—Innate Immune System—HLA-E—Graves' disease	0.000317	0.0103	CbGpPWpGaD
Olopatadine—S100B—Innate Immune System—HLA-E—Graves' disease	0.000299	0.00976	CbGpPWpGaD
Olopatadine—S100A12—Immune System—IFIH1—Graves' disease	0.000234	0.00764	CbGpPWpGaD
Olopatadine—S100A12—Innate Immune System—HLA-B—Graves' disease	0.000226	0.00736	CbGpPWpGaD
Olopatadine—S100B—Immune System—IFIH1—Graves' disease	0.000222	0.00723	CbGpPWpGaD
Olopatadine—S100B—Innate Immune System—HLA-B—Graves' disease	0.000213	0.00696	CbGpPWpGaD
Olopatadine—S100A12—Immune System—HLA-E—Graves' disease	0.000184	0.00601	CbGpPWpGaD
Olopatadine—HRH1—Class A/1 (Rhodopsin-like receptors)—TSHR—Graves' disease	0.000184	0.00601	CbGpPWpGaD
Olopatadine—S100A12—Immune System—CD40—Graves' disease	0.00018	0.00588	CbGpPWpGaD
Olopatadine—S100A12—Immune System—CTLA4—Graves' disease	0.000178	0.00579	CbGpPWpGaD
Olopatadine—S100B—Immune System—HLA-E—Graves' disease	0.000174	0.00569	CbGpPWpGaD
Olopatadine—S100B—Immune System—CD40—Graves' disease	0.00017	0.00556	CbGpPWpGaD
Olopatadine—S100B—Immune System—CTLA4—Graves' disease	0.000168	0.00548	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—TSHR—Graves' disease	0.000152	0.00497	CbGpPWpGaD
Olopatadine—S100A12—Immune System—HLA-DQB1—Graves' disease	0.000146	0.00477	CbGpPWpGaD
Olopatadine—HRH1—GPCR ligand binding—TSHR—Graves' disease	0.00014	0.00458	CbGpPWpGaD
Olopatadine—S100B—Immune System—HLA-DQB1—Graves' disease	0.000138	0.00451	CbGpPWpGaD
Olopatadine—S100A12—Immune System—CD8A—Graves' disease	0.000137	0.00445	CbGpPWpGaD
Olopatadine—S100A12—Innate Immune System—CD4—Graves' disease	0.000135	0.00439	CbGpPWpGaD
Olopatadine—S100A12—Immune System—HLA-B—Graves' disease	0.000131	0.00428	CbGpPWpGaD
Olopatadine—S100B—Immune System—CD8A—Graves' disease	0.000129	0.00421	CbGpPWpGaD
Olopatadine—S100B—Innate Immune System—CD4—Graves' disease	0.000127	0.00415	CbGpPWpGaD
Olopatadine—S100B—Immune System—HLA-B—Graves' disease	0.000124	0.00405	CbGpPWpGaD
Olopatadine—S100A12—Immune System—IL2RA—Graves' disease	0.000123	0.00401	CbGpPWpGaD
Olopatadine—S100A12—Immune System—HLA-A—Graves' disease	0.000122	0.00397	CbGpPWpGaD
Olopatadine—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCL10—Graves' disease	0.000119	0.00388	CbGpPWpGaD
Olopatadine—S100B—Immune System—IL2RA—Graves' disease	0.000116	0.0038	CbGpPWpGaD
Olopatadine—S100B—Immune System—HLA-A—Graves' disease	0.000115	0.00375	CbGpPWpGaD
Olopatadine—S100A12—Immune System—HLA-DRB1—Graves' disease	0.000111	0.00363	CbGpPWpGaD
Olopatadine—S100A12—Immune System—ICAM1—Graves' disease	0.000107	0.00348	CbGpPWpGaD
Olopatadine—S100B—Immune System—HLA-DRB1—Graves' disease	0.000105	0.00343	CbGpPWpGaD
Olopatadine—S100B—Immune System—ICAM1—Graves' disease	0.000101	0.00329	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—CXCL10—Graves' disease	9.85e-05	0.00321	CbGpPWpGaD
Olopatadine—HRH1—GPCR ligand binding—CXCL10—Graves' disease	9.07e-05	0.00296	CbGpPWpGaD
Olopatadine—S100A12—Immune System—IFNG—Graves' disease	8.12e-05	0.00265	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—TSHR—Graves' disease	7.94e-05	0.00259	CbGpPWpGaD
Olopatadine—S100A12—Immune System—CD4—Graves' disease	7.85e-05	0.00256	CbGpPWpGaD
Olopatadine—S100B—Immune System—IFNG—Graves' disease	7.68e-05	0.0025	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—IL2RA—Graves' disease	7.53e-05	0.00245	CbGpPWpGaD
Olopatadine—S100B—Immune System—CD4—Graves' disease	7.42e-05	0.00242	CbGpPWpGaD
Olopatadine—S100A12—Immune System—IL1B—Graves' disease	7.25e-05	0.00236	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—TSHR—Graves' disease	7.21e-05	0.00235	CbGpPWpGaD
Olopatadine—S100B—Immune System—IL1B—Graves' disease	6.85e-05	0.00223	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—CXCL10—Graves' disease	5.13e-05	0.00167	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—CXCL10—Graves' disease	4.66e-05	0.00152	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—TSHR—Graves' disease	4.26e-05	0.00139	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—IL2RA—Graves' disease	3.92e-05	0.00128	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—IL2RA—Graves' disease	3.56e-05	0.00116	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—GC—Graves' disease	3.15e-05	0.00103	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—CXCL10—Graves' disease	2.75e-05	0.000897	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—B3GNT2—Graves' disease	2.39e-05	0.000778	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—IL2RA—Graves' disease	2.1e-05	0.000685	CbGpPWpGaD
